15/02/2005 - 21:00

Solbec psoriasis trial complete

15/02/2005 - 21:00

Bookmark

Save articles for future reference.

SOLBEC Pharmaceuticals has announced that its safety trial of Coamsine in the treatment of psoriasis has finished successfully and ahead of schedule.This clinical trial, which was designed to demonstrate the safety of the compound under test, was conducted in three stages.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options